Antibodies against angiotensin II type 1 and endothelin-1 type A receptors are associated with microvascular obstruction after revascularized ST-elevation myocardial infarction.

MLA

Civieri, Giovanni, et al. “Antibodies against Angiotensin II Type 1 and Endothelin-1 Type A Receptors Are Associated with Microvascular Obstruction after Revascularized ST-Elevation Myocardial Infarction.” European Heart Journal Open, vol. 4, no. 6, Nov. 2024, pp. 1–4. EBSCOhost, https://doi.org/10.1093/ehjopen/oeae099.

APA

Civieri, G., Iop, L., Cozzi, E., Iliceto, S., & Tona, F. (2024). Antibodies against angiotensin II type 1 and endothelin-1 type A receptors are associated with microvascular obstruction after revascularized ST-elevation myocardial infarction. European Heart Journal Open, 4(6), 1–4. https://doi.org/10.1093/ehjopen/oeae099

Chicago

Civieri, Giovanni, Laura Iop, Emanuele Cozzi, Sabino Iliceto, and Francesco Tona. 2024. “Antibodies against Angiotensin II Type 1 and Endothelin-1 Type A Receptors Are Associated with Microvascular Obstruction after Revascularized ST-Elevation Myocardial Infarction.” European Heart Journal Open 4 (6): 1–4. doi:10.1093/ehjopen/oeae099.